Monthly injections can stop the progress of dry age-relation macular degeneration, the UK’s Sunday Express reports.
The treatment stops the body’s own immune system from attacking healthy eye cells.
Experts said the breakthrough signaled a new era for patients suffering from dry age-related macular degeneration, a type of blindness that was previously untreatable.
Trials in the UK, Europe and the United States found that new drugs injected into the eye can preserve sight by slowing the spread of the disease.
Dry macular degeneration happens when the immune system malfunctions and destroys healthy cells.
Researchers found two new injectable drugs: Pegcetacoplan and Zimura. Both work by introducing proteins that stop the faulty inflammatory process from attacking eye cell membranes.
The monthly treatment has so far been tested in 286 patients.